Table 2 Studies investigating the effects of treatments on the NVU in FGR.

From: Effects of fetal growth restriction on the perinatal neurovascular unit and possible treatment targets

Authors

Experimental model

Intervention trialled

Key findings

Castillo-Melendez et al. (2017)44

Lambs delivered naturally at term (~147 days) and euthanised 24 h later

FGR induced via SUAL at ~105 days gestation

Antenatal treatment with either saline (placebo) or Melatonin infusion (0.1 mg/kg) started 4 h after SUAL surgery

No significant difference in blood vessel density and proliferation (VEGF expression) between FGR group and intervention group

Improved endothelial cell proliferation (Glut1 expression) with melatonin intervention

Normalisation of pericyte and astrocyte end-feet coverage with melatonin intervention

Albumin extravasation and microhaemorrhage prevention in the treatment group

Chand et al. (2021)49

Term FGR piglets (<10th percentile birth weight) and NG piglets (10–90th) percentile

Euthanasia on postnatal day 4

cECFC/MSC/sham treatment administered on postnatal day 1

cECFC treatment increased vessel density while MSC had no effect

cECFC treatment restored total vascular length as well as partially improved vessel branching

cECFC reduced incidences of albumin and IgG-labelled area

cECFC increased GFAP-positive vessel coverage

cECFC microglial morphology similar to NG

cECFC decreased glial activation and increased modulation of inflammatory mediators

cECFC reduces neuronal apoptosis in the brain

Chand et al. (2022)48

FGR piglets (<10th percentile birth weight) and NG piglets (10–90th percentile)

Euthanasia on postnatal day 4

Liquid ibuprofen was given via an oral dose of 20 mg/kg/day on postnatal day 1 and 10 mg/kg/day on days 2 and 3

Intervention group displayed juxtavascular astrocyte and microglia resting morphology similar to that observed in NG group

Ibuprofen reduced the frequency of hypertrophic astrocyte end-feet and normalised vessel coverage

Ibuprofen reduced the number of activated juxtavascular microglia

Ibuprofen reduced pro-inflammatory cytokines and increased anti-inflammatory mediator

Albumin and IgG extravasation reduced in ibuprofen treatment compared to untreated FGR

Increased apoptosis in FGR ameliorated following ibuprofen treatment

Decreased ZO-1 vessel coverage not recovered by ibuprofen treatment

Malhotra et al. (2020)45

Twin lambs delivered (127 days), intubated and ventilated then euthanised 24 h later

FGR induced at 88 days gestation via SUAL in one twin

Allogeneic umbilical cord blood mononuclear cells (25 million/kg) were suspended in 2–3 ml of sterile saline and given intravenously (via the umbilical vein) to preterm ventilated lambs at 1 h of life

UCBC therapy reduced the number of activated microglial cells

UCBC therapy resulted in significantly more increased endothelial cell coverage compared to FGR

UCBC therapy normalised co-localisation of pericyte coverage

UCBC therapy decreased albumin extravasation into the brain parenchyma

Bell et al. (2023)113

Preterm lambs studied at 127 days gestation

FGR induced via SUAL at ~88 days gestation

1 × 107 ECFCs delivered intravenously to fetal lambs in utero at 113 days gestation

ECFC administration increased both vessel sizes and overall vascular density throughout grey and white matter regions of both AGA and FGR lambs

ECFC administration increased vascular astrocyte coverage in the cortical grey matter and subcortical white matter of both AGA and FGR lambs

ECFC administration increased VEGF expression in the cortical grey matter and subcortical white matter of both AGA and FGR lambs

ECFC administration produced no significant difference in vascular pericyte coverage in the brains of either AGA or FGR lambs

ECFC administration produced no significant difference in vascular GLUT1 expression in the brains of either AGA or FGR lambs

  1. cECFC combined endothelial colony-forming cells, FGR fetal growth restriction, GFAP glial fibrillary acidic protein, Glut1 glucose transporter 1, MSC mesenchymal stromal cells, NG normally grown, SUAL single umbilical artery ligation, UCBC umbilical cord blood cell, VEGF vascular endothelial growth factor, ZO-1 zonula occludens-1.